← quant terminal / congress tracker

Richard Blumenthal

Disclosed transactions, newest first. Amounts are STOCK Act range midpoints; disclosures lag actual trades by up to 45 days.

2026-09-23 SELL STLNStarling Oncology, Inc. - Common Stock $1,001–$15,000
2026-09-22 SELL STLNStarling Oncology, Inc. - Common Stock $1,001–$15,000
2026-09-22 SELL STLNStarling Oncology, Inc. - Common Stock $15,001–$50,000
2026-09-18 SELL STLNStarling Oncology, Inc. - Common Stock $1,001–$15,000
2026-09-18 SELL STLNStarling Oncology, Inc. - Common Stock $15,001–$50,000